Chrysostomakis, Stavros I <br/><br/>
Angiotensin II type 1 receptor inhibition is associated with reduced tachyarrhythmia-induced ventricular interstitial fibrosis in a goat atrial fibrillation model.  [electronic resource] 

 -  Cardiovascular drugs and therapy  Oct 2007 
 - 357-65 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0920-3206 
<br/><br/><label>Standard No.: </label>10.1007/s10557-007-6053-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Atrial Fibrillation--drug therapy<br/>Benzimidazoles--administration & dosage<br/>Biphenyl Compounds<br/>Cardiac Pacing, Artificial<br/>Disease Models, Animal<br/>Female<br/>Fibrosis--etiology<br/>Goats<br/>Male<br/>Myocardium--pathology<br/>Receptor, Angiotensin, Type 1--drug effects<br/>Tachycardia--complications<br/>Tetrazoles--administration & dosage<br/>Ventricular Remodeling--drug effects